FdaApplication
NDA 202231
Identifiers
- fda_app_no: NDA202231
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2011-06-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 500MCG/VIAL | POWDER;INTRAVENOUS |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/VIAL | POWDER;INTRAVENOUS |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 200MCG/VIAL | POWDER;INTRAVENOUS |
3 products